globalworldcitizen.com

Purdue Pharma’s Revised Bankruptcy Plan Offers Billions for Opioid Crisis Victims

Published Date: March 19, 2025 ✍️ Author: Global World Citizen News Team 📰 Source: GlobalWorldCitizen.com

Purdue Pharma’s Revised Bankruptcy Plan Offers Billions for Opioid Crisis Victims

Purdue Pharma has submitted a new bankruptcy settlement plan, proposing over $7.4 billion in compensation, including up to $7 billion from the Sackler family, to help victims of the opioid epidemic. The plan comes nine months after the U.S. Supreme Court struck down a previous agreement and marks a significant shift in the legal battle surrounding the pharmaceutical giant.

 


Key Details of the New Settlement

💰 Sackler Family Contributions & Payout Structure

  • The billionaire Sackler family will pay up to $7 billion, with an initial $1.5 billion upfront payment.
  • Additional $6.5 billion will be paid in installments over the next 15 years.
  • An extra $500 million could be added if the sale of the Sacklers’ international pharmaceutical holdings surpasses a certain valuation.

🏛 Purdue Pharma’s Transformation

  • Purdue Pharma will be dissolved, and its assets will be transferred to a new public benefit company.
  • The Sacklers will have no ownership or control over the new entity.
  • The new company will focus on combating the opioid crisis and improving public health, with governance overseen by state-appointed officials.

⚖ Creditors Have a Choice

  • Victims and states can opt-in to receive settlement funds or opt-out and retain the right to sue members of the Sackler family individually.
  • If all eligible claimants opt-in, the full $7.4 billion will be distributed.

🏦 Purdue’s Contribution

  • Purdue will provide all its remaining assets, including $900 million in cash, toward the settlement.

How Does This Plan Differ From the Previous One?

🚨 Stronger Legal Protections for Victims

  • The previous $6 billion settlement, blocked by the Supreme Court in 2024, would have shielded the Sackler family from further civil lawsuits.
  • Under the new plan, victims retain the right to sue if they choose not to opt into the settlement.

🗣 Supreme Court’s Rejection of the Old Plan

  • In a 5-4 ruling, Justice Neil Gorsuch struck down Purdue’s previous proposal, stating, “Nothing in present law authorizes the Sackler discharge.”
  • The revised plan removes automatic legal protections for the Sacklers, making it more legally viable.

Financial Impact on the Sackler Family

📉 Net Worth Decline

  • The Sackler family’s fortune was estimated at $10.8 billion in 2020 but fell to $5.2 billion in early 2024.
  • If this settlement is fully paid, their remaining wealth will shrink even further.

🔎 No Longer Involved in Purdue Pharma

  • The Sacklers left Purdue’s board in 2018 and claim they had no involvement in the company’s operations since then.

Background: Purdue Pharma & the Opioid Crisis

💊 OxyContin’s Role in the Epidemic

  • Purdue Pharma, the maker of OxyContin, has faced numerous lawsuits for its role in the opioid crisis, which has contributed to hundreds of thousands of overdose deaths.
  • The Sackler family has been accused of aggressively marketing OxyContin, despite knowing the risks of addiction.

⚖ Legal Battles & Previous Settlements

  • Purdue declared bankruptcy in 2019 after facing lawsuits from multiple states.
  • The initial 2021 settlement proposal was for $4.5 billion, later increased to $6 billion, but was rejected in 2024.

🚨 Sackler Family’s Defense

  • The Sacklers deny wrongdoing, stating they acted lawfully in all respects and that OxyContin unexpectedly became part of the opioid crisis.

What’s Next?

📝 Approval Process

  • The plan requires approval from the bankruptcy court and widespread creditor participation.
  • Legal experts believe it has a stronger chance of approval due to its opt-out provision.

💰 Compensation for Victims

  • $850 million will go directly to individual victims of opioid addiction, including:
    ✅ Patients who became addicted to OxyContin.
    ✅ Children born with opioid withdrawal symptoms.

🚨 The Future of Purdue’s Public Benefit Company

  • If approved, the new company will focus on funding addiction treatment and opioid crisis prevention efforts.

🔔 Stay tuned for updates as the legal battle unfolds! 🚀